Full weekend edition + daily archive:
https://burns-media.com/biotech/?utm_source=mastodon&utm_medium=social&utm_campaign=biotech_weekly
Subscribe — free, weekday mornings.
Full briefing — the morning intelligence for investors and analysts:
https://burns-media.com/biotech/archive/2026-05-22?utm_source=mastodon&utm_medium=social&utm_campaign=biotech_daily
Free. Delivered by 7 AM ET, every weekday.
Experimental Drug Yields Dramatic Weight Loss
https://fed.brid.gy/r/https://www.nytimes.com/2026/05/21/science/retatrutide-weight-loss-drug.html
We reposting an article of Monday about post-marketing surveillance for biosimilars.
#Biosimilars #Pharmacovigilance #ClinicalResearch #RealWorldEvidence #CDSCO #Pharma #CRO #ClinicalTrials
https://genelifecr.blogspot.com/2026/05/post-marketing-surveillance-for.html
Full briefing — the morning intelligence for investors and analysts:
https://burns-media.com/biotech/archive/2026-05-21?utm_source=mastodon&utm_medium=social&utm_campaign=biotech_daily
Free. Delivered by 7 AM ET, every weekday.
OncoTherapy Science shares struggle amid clinical delays and prolonged investor confidence concerns recently.
#OncoTherapyScience #BiotechStocks #ClinicalTrials #StockMarket
https://meyka.com/blog/oncotherapy-science-stock-slumps-44-in-three-years-on-clinical-delays-2105/